Filter
883
Text search:
adverse
events
Featured
Recommendations
106
New Publications
189
Language
Document type
No document type
440
Guidelines
164
Studies & Reports
133
Manuals
64
Strategic & Response Plan
26
Training Material
22
Fact sheets
21
Situation Updates
5
Resource Platforms
4
Online Courses
2
Brochures
1
Infographics
1
Countries / Regions
Global
35
India
33
Western and Central Europe
24
South Africa
21
Kenya
18
Latin America and the Carribbean
17
Africa
17
Ghana
13
Ethiopia
12
Uganda
11
Philippines
11
Nepal
11
Nigeria
10
Tanzania
10
Eastern Europe
9
Syria
8
Bangladesh
8
Malawi
7
Ukraine
7
Rwanda
6
USA
5
South Sudan
5
Cambodia
5
South–East Asia Region
5
Sierra Leone
4
Namibia
4
Myanmar / Burma
4
Middle East and North Africa
4
Asia
4
Senegal
3
Pakistan
3
Zambia
3
Brazil
3
Lesotho
3
Guinea
2
Liberia
2
Congo, Democratic Republic of
2
Cameroon
2
Zimbabwe
2
Somalia
2
Germany
2
China
2
Indonesia
2
Mozambique
2
Sudan
2
Colombia
2
Botswana
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Other region
2
Venezuela
2
Russia
2
Burkina Faso
1
Mali
1
Niger
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Chad
1
Gambia
1
Mauritania
1
North Macedonia
1
Ecuador
1
El Salvador
1
Sri Lanka
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
Bhutan
1
Laos
1
Canada
1
Tajikistan
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
226
Clinical Guidelines
114
Key Resources
62
Public Health
56
Women & Child Health
50
Capacity Building
14
Pharmacy & Technologies
8
Toolboxes
Mental Health
106
COVID-19
83
TB
63
HIV
49
Planetary Health
45
Caregiver
34
Pharmacy
31
Conflict
29
NTDs
28
AMR
26
NCDs
22
Rapid Response
21
Disability
17
Global Health Education
17
Ebola & Marburg
13
Refugee
13
Specific Hazards
13
2.0 Rapid Response
13
Natural Hazards
12
Polio
5
Malaria
5
Zika
4
Health Financing Toolbox
4
Cholera
2
Social Ethics
2
12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.
This document is also available in Arabic and Portuguese.
5th edition.
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz
...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Med J DY Patil Univ 2017;10:229-33
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid
...
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisat
...
4th edition. A manual for clinics, community health centers and district hospitals
Technical Guidelines for Integrated Disease Surveillance and Response in the African Region
recommended
3rd edition.
The third edition of the Integrated Disease Surveillance and Response (IDSR) Technical Guidelines was prepared by the WHO Health Emergencies (WHE) Programme with the active participation and involvement of programmes dealing with disease surveillance at the WHO Regional Office for Afri
...
This editorial will consider the often heralded and sometimes belittled Surgical Safety Checklist (SSCL) for its general benefits, potential utility, and range of evidence attesting to its value in quality and safety improvement.
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?